Published in Ann Hepatol on September 05, 2012
Concern Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infect Dis (2014) 1.37
Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis. Int J Public Health (2015) 0.88
Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission. BMC Res Notes (2015) 0.80
Hepatitis C virus seroprevalence in the general female population from 8 countries. J Clin Virol (2015) 0.77
Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3. World J Hepatol (2015) 0.76
Distribution of hepatitis C virus genotypes in Arak city, central province of Iran. Iran J Microbiol (2016) 0.75
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals. Pharmgenomics Pers Med (2017) 0.75
Abstracts of the HIV & Hepatitis in the Americas 2017 - Congress. J Int AIDS Soc (2017) 0.75
World hepatitis day. Fighting hepatitis C in Latin America and the Caribbean; an urgent call. J Int AIDS Soc (2017) 0.75
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet (2006) 7.17
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis (2008) 3.38
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS (2010) 2.04
Changes in renal function during acute spinal cord injury: implications for pharmacotherapy. Spinal Cord (2013) 1.98
Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother (2004) 1.96
Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol (2006) 1.77
Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. Ann Emerg Med (2008) 1.72
Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ (2010) 1.72
The cost-effectiveness of screening for colorectal cancer. CMAJ (2010) 1.67
Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res (2006) 1.64
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J Am Coll Cardiol (2005) 1.61
Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med (2004) 1.52
Determinants of hospital length of stay among patients with pneumonia admitted to a large Canadian hospital from 1991 to 2001. Can Respir J (2005) 1.52
Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia. CMAJ (2002) 1.43
The effect of waiting time on pain intensity after elective surgical lumbar discectomy. Spine J (2013) 1.42
Bioavailability of two oral formulations of cyclosporin A in uremic children before renal transplantation. Pediatr Transplant (1998) 1.38
Design parameters of a miniaturized piezoelectric underwater acoustic transmitter. Sensors (Basel) (2012) 1.33
Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population. Diabetes (2012) 1.24
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21
Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother (2002) 1.19
Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urol Oncol (2009) 1.17
An efficient photocatalyst structure: TiO(2)(B) nanofibers with a shell of anatase nanocrystals. J Am Chem Soc (2009) 1.15
Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum (2011) 1.14
Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med (2003) 1.13
A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding. J Clin Epidemiol (2007) 1.11
The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures. Addiction (2010) 1.10
Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells. PLoS One (2010) 1.10
The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States. Hepatology (2013) 1.08
Personal privacy and public health: potential impacts of privacy legislation on health research in Canada. Can J Public Health (2008) 1.08
Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatr Respir Rev (2013) 1.05
Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. J Infect Dis (2004) 1.04
The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan. Value Health (2012) 1.01
Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico. Arch Med Res (2006) 0.99
The role of calcium in hypoxia-induced signal transduction and gene expression. Cell Calcium (2004) 0.99
Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int J Cancer (2009) 0.99
Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation (2009) 0.99
Pharmacokinetic/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat. J Pharmacol Exp Ther (2001) 0.98
Review of patient-reported outcome measures in chronic hepatitis C. Health Qual Life Outcomes (2012) 0.98
Degradation of carbazole by microbial cells immobilized in magnetic gellan gum gel beads. Appl Environ Microbiol (2007) 0.98
Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study. BMC Gastroenterol (2014) 0.97
Development of canadian safety indicators for medication use. Healthc Q (2008) 0.97
Enhanced performance of air-cathode two-chamber microbial fuel cells with high-pH anode and low-pH cathode. Bioresour Technol (2010) 0.97
Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. J Int Assoc Physicians AIDS Care (Chic) (2008) 0.96
Economic burden associated with patients diagnosed with hepatitis C. Clin Ther (2011) 0.95
Limited sampling model for area-under-the-curve monitoring in pediatric patients receiving either Sandimmune or Neoral cyclosporin A oral formulations. Pediatr Transplant (1999) 0.95
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. J Med Econ (2011) 0.94
The risk of death associated with delayed coronary artery bypass surgery. BMC Health Serv Res (2006) 0.94
The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection. Paediatr Respir Rev (2013) 0.94
Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion. Mol Cell Endocrinol (2012) 0.93
Socioeconomic status and hospital utilization among younger adult pneumonia admissions at a Canadian hospital. BMC Health Serv Res (2006) 0.93
Do longer delays for coronary artery bypass surgery contribute to preoperative mortality in less urgent patients? Med Care (2006) 0.92
Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model. Appl Health Econ Health Policy (2013) 0.91
A multinational study of health state preference values associated with chronic myelogenous leukemia. Value Health (2009) 0.91
Modeling for gellan gum production by Sphingomonas paucimobilis ATCC 31461 in a simplified medium. Appl Environ Microbiol (2006) 0.90
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients. Ann Hepatol (2011) 0.90
Hierarchical priors for bias parameters in Bayesian sensitivity analysis for unmeasured confounding. Stat Med (2012) 0.89
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial. Can J Cardiol (2007) 0.89
Locus on chromosome 6p linked to elevated HDL cholesterol serum levels and to protection against premature atherosclerosis in a kindred with familial hypercholesterolemia. Circ Res (2003) 0.88
Do specialist transport personnel improve hospital outcome in critically ill patients transferred to higher centers? A systematic review. J Crit Care (2006) 0.88
Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis. Crit Care Med (1997) 0.87
Structural frameworks and key model parameters in cost-effectiveness analyses for current and future treatments of chronic hepatitis C. Value Health (2011) 0.87
Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of diclofenac in the rat. J Pharmacol Exp Ther (1997) 0.87
Magnetic nano-beads based separation combined with propidium monoazide treatment and multiplex PCR assay for simultaneous detection of viable Salmonella Typhimurium, Escherichia coli O157:H7 and Listeria monocytogenes in food products. Food Microbiol (2013) 0.87
The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes. Eur J Gastroenterol Hepatol (2012) 0.86
Extending logistic regression to model diffuse interactions. Stat Med (2005) 0.86
Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. Br J Pharmacol (2008) 0.86
Pharmacokinetics of pelanserin in healthy volunteers. Proc West Pharmacol Soc (1992) 0.86
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan. Hepatol Int (2015) 0.86
Assessing the relationship between computational speed and precision: a case study comparing an interpreted versus compiled programming language using a stochastic simulation model in diabetes care. Pharmacoeconomics (2010) 0.85
Deproteinization of gellan gum produced by Sphingomonas paucimobilis ATCC 31461. J Biotechnol (2006) 0.85
Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer (2014) 0.85
Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol Genet Metab (2004) 0.85
A simple approach to fitting Bayesian survival models. Lifetime Data Anal (2003) 0.85
Is health-related quality of life improving after stroke? A comparison of health utilities indices among Canadians with stroke between 1996 and 2005. Stroke (2010) 0.85
Mutations in MODY genes are not common cause of early-onset type 2 diabetes in Mexican families. JOP (2005) 0.85
Alumina nanofibers grafted with functional groups: a new design in efficient sorbents for removal of toxic contaminants from water. Water Res (2009) 0.85
Pharmacokinetics of nifedipine slow release tablet in Mexican subjects: further evidence for an oxidation polymorphism. J Clin Pharmacol (1989) 0.84
The impact of reference pricing of nonsteroidal anti-inflammatory agents on the use and costs of analgesic drugs. Health Serv Res (2005) 0.84
Pharmacokinetic-pharmacodynamic modeling of tolmetin antinociceptive effect in the rat using an indirect response model: a population approach. J Pharmacokinet Biopharm (1998) 0.84
Humic substance-mediated reduction of iron(III) oxides and degradation of 2,4-D by an alkaliphilic bacterium, Corynebacterium humireducens MFC-5. Microb Biotechnol (2012) 0.84
Scalable microbial fuel cell (MFC) stack for continuous real wastewater treatment. Bioresour Technol (2011) 0.84
Sorption induced structural deformation of sodium hexa-titanate nanofibers and their ability to selectively trap radioactive Ra(II) ions from water. Phys Chem Chem Phys (2009) 0.83
Presence of mutation m.14484T>C in a Chinese family with maternally inherited essential hypertension but no expression of LHON. Biochim Biophys Acta (2012) 0.83
Extracellular quinones affecting methane production and methanogenic community in paddy soil. Microb Ecol (2013) 0.82
Treatment costs in Canada of health conditions resulting from chronic hepatitis B infection. J Clin Gastroenterol (2004) 0.82
Predicting hospitalization among HIV-infected antiretroviral naïve patients starting HAART: determining clinical markers and exploring social pathways. AIDS Care (2008) 0.82
Water versus acetone-HCl extraction of digitalis-like factor from guinea-pig heart. Biochem Pharmacol (1982) 0.82
Mechanisms underlying the anti-inflammatory activity and gastric safety of acemetacin. Br J Pharmacol (2007) 0.82
Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B. Appl Health Econ Health Policy (2008) 0.82
Chances of late surgery in relation to length of wait lists. BMC Health Serv Res (2005) 0.82
Cost-effectiveness of therapies for melanoma. Expert Rev Pharmacoecon Outcomes Res (2015) 0.82
Assessing the impact of censoring of costs and effects on health-care decision-making: an example using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Value Health (2007) 0.81
Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment. Antimicrob Agents Chemother (2009) 0.81
Pharmacokinetic-pharmacodynamic modeling: why? Arch Med Res (2001) 0.81
Mechanisms involved in the cardiovascular alterations immediately after spinal cord injury. Life Sci (2001) 0.81
Trauma evaluation of patients with chest injury in the 2008 earthquake of Wenchuan, Sechuan, China. World J Surg (2010) 0.81
Pharmacokinetic-pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats. Br J Pharmacol (2009) 0.81
Predictors of interleukin-33 and thymic stromal lymphopoietin levels in cord blood. Pediatr Allergy Immunol (2015) 0.80